Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Promyelocytic, Acute 12Leukemia 8Leukemia, Myeloid, Acute 7Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Myelodysplastic Syndromes 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Congenital Abnormalities 2Skin Neoplasms 1Oropharyngeal Neoplasms 1Neutropenia 1Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hematologic Neoplasms 1Hematologic Diseases 1Head and Neck Neoplasms 1Childhood Acute Promyelocytic Leukemia With PML-RARA 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1Breast Cancer Female 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Tamoxifen 2pegfilgrastim 1exemestane 1abemaciclib 1Tretinoin 1Tocopherols 1Standard of Care 1Mifepristone 1Letrozole 1Isotretinoin 1Dexmedetomidine 1Cannabidiol 1Bupivacaine 1Anastrozole 1Alitretinoin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Breast Cancer Female × Tretinoin × Clear all
NCT05016349 2021-08-23

Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.

Kafrelsheikh University

Phase 3 Unknown
160 enrolled
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡